Mylan Seeks Authorization for International Research and Development
February 13, 2025
February 13, 2025
WASHINGTON, Feb. 13 (TNSFR) -- Mylan Inc. has applied for federal authorization to bring select pharmaceutical ingredients into the United States for internal testing and global clinical trials. The company, based in Morgantown, West Virginia, has submitted its request to handle multiple Schedule II compounds, including amphetamine, methylphenidate, oxycodone, hydromorphone, methadone, morphine, and fentanyl.
These substances are commonly used in the treatment of attention deficit . . .
These substances are commonly used in the treatment of attention deficit . . .